Alert: NORML has submitted its public comments to the Drug Enforcement Administration in support of reclassifying botanical cannabis.

“The HHS appropriately determined that neither scientific evidence nor real-world clinical experience support cannabis’ inclusion in either category,” NORML acknowledges. Specifically, NORML cites a 2022 national survey of family practice doctors, internists, nurse practitioners, and oncologists that concluded, “Over two-thirds (68.9%) of clinicians surveyed believe that cannabis has medicinal uses and just over a quarter […]